# Study to Evaluate Safety, Tolerability and Pharmacokinetics of VM-1500A-LAI Single and Multiple Ascending Doses in Healthy Subjects

> **NCT03706911** · PHASE1 · COMPLETED · sponsor: **Viriom** · enrollment: 27 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** VM-1500A-LAI

## Key facts

- **NCT ID:** NCT03706911
- **Lead sponsor:** Viriom
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-21
- **Primary completion:** 2020-03-27
- **Final completion:** 2020-05-18
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2021-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03706911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03706911, "Study to Evaluate Safety, Tolerability and Pharmacokinetics of VM-1500A-LAI Single and Multiple Ascending Doses in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03706911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*